Lexicon Pharmaceuticals
LXRX
#7128
Rank
ยฃ0.39 B
Marketcap
ยฃ0.93
Share price
-0.78%
Change (1 day)
53.47%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -ยฃ53.62 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ70.86 Million. In 2024 the company made an earning of -ยฃ0.15 Billion a decrease over its 2023 earnings that were of -ยฃ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ53.62 Million-63.65%
2024 -ยฃ0.15 Billion13.15%
2023 -ยฃ0.14 Billion73.74%
2022 -ยฃ75.04 Million16.16%
2021 -ยฃ64.6 Million49.82%
2020 -ยฃ43.12 Million-147.19%
2019 ยฃ91.35 M-203.42%
2018 -ยฃ88.34 Million-15.31%
2017 -ยฃ0.11 Billion0.2%
2016 -ยฃ0.11 Billion2920.7%
2015 -ยฃ3.45 Million-95.33%
2014 -ยฃ73.88 Million-3.61%
2013 -ยฃ76.64 Million-5.52%
2012 -ยฃ81.12 Million-4.17%
2011 -ยฃ84.66 Million15.5%
2010 -ยฃ73.3 Million8.36%
2009 -ยฃ67.64 Million-4.81%
2008 -ยฃ71.06 Million28.79%
2007 -ยฃ55.17 Million35.71%
2006 -ยฃ40.66 Million52.91%
2005 -ยฃ26.59 Million-23.89%
2004 -ยฃ34.93 Million-24.19%
2003 -ยฃ46.08 Million-0.48%
2002 -ยฃ46.3 Million44.12%
2001 -ยฃ32.12 Million23.01%
2000 -ยฃ26.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ5.22 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.73 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.78 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.39 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ49.16 M-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.2 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ17.11 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.49 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ6.99 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA